Conference abstractPublished 5 Aug 2013
Comprehensive evaluation of patient and tumor characteristic identify different subsets of postmenopausal breast cancers that need different treatments
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Androgen-Excess Theory of Breast Cancer points to androgen excess as the principal growth stimulator of both estrogen receptor(ER)-positive cancers, by conversion to estrogens, and of ER-negative cancers, by binding to androgen receptor (AR). The theory also highlights the need to investigate the hormonal status of the patient and not only the characteristics of the tumor. Accordingly, we examined the serum testosterone levels (high/low), ER status (positive/negative), and AR status (positive/ negative) in a cohort of 534 postmenopausal breast cancer patients and identified different subsets of cancers. Our studies show different outcomes in the different groups (preliminary data) and suggest additional treatments to standard therapies: ER-positive and high testosterone levels: Hypertestosteronemia largely originates from ovarian interstitial-cell hyperplasia → medical oophorectomy. ER-positive and low testosterone levels: Androgen excess is of adrenal origin and causes increased formation of estrone sulfate → sulfatase inhibitors, that inhibit the conversion of estrone sulfate to estrone and the conversion of DHEAS to DHEA (the precursor of androstenedione). ER-negative and AR-positive and high testosterone levels: Androgen excess directly stimulate cancer growth by binding to AR → antiandrogens (medical oophorectomy might also be considered). ER-negative and AR-negative and high testosterone levels: Androgens cannot act either by conversion to estrogens or by binding to AR; they probably stimulate increased production of Epidermal Growth Factor that stimulates cancer growth by binding to EGF-Receptor → EGFR inhibitors (medical oophorectomy may be considered). ER-negative and AR-positive and low testosterone levels: → Antiandrogens ER-negative and AR-negative and low testosterone levels: Non hormone-dependent tumors.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Giorgio Secreto”
